sotorasib
amgen
['lumakras', 'lung']
 the efficiency of lumakrastm was evaluated in the study of 124 patients with locally advanced or metastatic kras g12c-mutated non-small cell lung cancer with disease progression after receiving therapy with an immune checkpoint inhibitor and/or platinum-based chemotherapy.